BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 15687675)

  • 1. Insulin-like growth factor and breast cancer risk: evidence from observational studies.
    Hankinson SE; Schernhammer ES
    Breast Dis; 2003; 17():27-40. PubMed ID: 15687675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
    Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE
    Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
    Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
    Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic features.
    Izzo L; Meggiorini ML; Nofroni I; Pala A; De Felice C; Meloni P; Simari T; Izzo S; Pugliese F; Impara L; Merlini G; Di Cello P; Cipolla V; Forcione AR; Paliotta A; Domenici L; Bolognese A
    G Chir; 2012 May; 33(5):153-62. PubMed ID: 22709450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenopausal levels of circulating insulin-like growth factor I and the risk of postmenopausal breast cancer.
    Rollison DE; Newschaffer CJ; Tao Y; Pollak M; Helzlsouer KJ
    Int J Cancer; 2006 Mar; 118(5):1279-84. PubMed ID: 16161053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
    Krajcik RA; Borofsky ND; Massardo S; Orentreich N
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
    Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
    Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
    Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.
    Yu H; Shu XO; Li BD; Dai Q; Gao YT; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1067-73. PubMed ID: 14578144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 and the risk of premenopausal breast cancer: a meta-analysis of literature.
    Sugumar A; Liu YC; Xia Q; Koh YS; Matsuo K
    Int J Cancer; 2004 Aug; 111(2):293-7. PubMed ID: 15197785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
    Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
    Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor-I and binding protein-3 and risk of cancer.
    Giovannucci E
    Horm Res; 1999; 51 Suppl 3():34-41. PubMed ID: 10592442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common genetic variation of insulin-like growth factor-binding protein 1 (IGFBP-1), IGFBP-3, and acid labile subunit in relation to serum IGF-I levels and mammographic density.
    Taverne CW; Verheus M; McKay JD; Kaaks R; Canzian F; Grobbee DE; Peeters PH; van Gils CH
    Breast Cancer Res Treat; 2010 Oct; 123(3):843-55. PubMed ID: 20155489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women.
    Grønbaek H; Flyvbjerg A; Mellemkjaer L; Tjønneland A; Christensen J; Sørensen HT; Overvad K
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1759-64. PubMed ID: 15533904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
    Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
    Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
    Diorio C; Brisson J; Bérubé S; Pollak M
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.
    Johansson H; Baglietto L; Guerrieri-Gonzaga A; Bonanni B; Mariette F; Macis D; Serrano D; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2004 Nov; 88(1):63-73. PubMed ID: 15538047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.